In lung cancer and melanoma, while a deficiency in COX10 decreased tumor neovascularization and decelerated tumor growth, it also led to an expanded region of ischemic necrosis and facilitated tumor metastasis [41]. This evidence concerns the gene COX10 and lung cancer.